Facet browsing currently unavailable
Page 3 of 20620 results
Sort by: relevance publication year
In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone) JOURNAL ARTICLE published 1 May 2006 in Clinical Cancer Research |
Antitumor Effects of a Novel Phenylbutyrate-Based Histone Deacetylase Inhibitor, (S)-HDAC-42, in Prostate Cancer JOURNAL ARTICLE published 1 September 2006 in Clinical Cancer Research |
Gene Targeting Meets Cell-Based Therapy: Raising the Tail, or Merely a Whimper? JOURNAL ARTICLE published 15 January 2017 in Clinical Cancer Research |
It Shouldn't Take Another 50 Years: Accelerating Momentum to End the Tobacco Epidemic JOURNAL ARTICLE published 1 April 2014 in Clinical Cancer Research |
The Context of Blood Vessels and Response to VEGF-Targeted Therapy JOURNAL ARTICLE published 15 December 2013 in Clinical Cancer Research |
Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive JOURNAL ARTICLE published 1 August 2018 in Clinical Cancer Research Research funded by University of Texas MD Anderson Cancer Center (CA 016672) |
Abstract IA02: The Treehouse Childhood Cancer Initiative JOURNAL ARTICLE published 15 June 2020 in Clinical Cancer Research |
Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma JOURNAL ARTICLE published 15 February 2018 in Clinical Cancer Research Research funded by HHS | NIH | National Cancer Institute (NCI) (R01CA152065) | HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) (R21NS091436) | B*Cured Foundation (n/a) |
High Serum Transforming Growth Factor-β1 Levels Predict Outcome in Hepatocellular Carcinoma Patients Treated with Sorafenib JOURNAL ARTICLE published 15 August 2015 in Clinical Cancer Research |
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate JOURNAL ARTICLE published 1 April 2016 in Clinical Cancer Research |
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer JOURNAL ARTICLE published 17 January 2023 in Clinical Cancer Research |
A Randomized Phase II Study Comparing Nivolumab with Carboplatin–Pemetrexed for EGFR-Mutated NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors (WJOG8515L) JOURNAL ARTICLE published 1 March 2022 in Clinical Cancer Research |
Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care JOURNAL ARTICLE published 1 November 2021 in Clinical Cancer Research Research funded by NCI (P30 CA008748,R01 CA251339) | NCI (U01 CA238444) |
Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions JOURNAL ARTICLE published 1 June 2017 in Clinical Cancer Research |
Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia JOURNAL ARTICLE published 15 August 2017 in Clinical Cancer Research |
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101) JOURNAL ARTICLE published 1 May 2023 in Clinical Cancer Research Research funded by National Cancer Institute (P30CA016672) | Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy (1U01 CA180964) |
Preoperative Serum Caveolin-1 as a Prognostic Marker for Recurrence in a Radical Prostatectomy Cohort JOURNAL ARTICLE published 15 August 2006 in Clinical Cancer Research |
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial JOURNAL ARTICLE published 16 February 2023 in Clinical Cancer Research Research funded by U.S. Department of Defense (W81XWH-18-1-0018) |
The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis JOURNAL ARTICLE published 15 March 2006 in Clinical Cancer Research |
Growth Inhibition of Human Multiple Myeloma Cells by an Oncolytic Adenovirus Carrying the CD40 Ligand Transgene JOURNAL ARTICLE published 1 August 2009 in Clinical Cancer Research |